{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:20:53Z","timestamp":1760188853872},"reference-count":36,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T00:00:00Z","timestamp":1172793600000},"content-version":"vor","delay-in-days":7184,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[1987,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We analysed the clinical and pathologic features of 42 patients with immunologically confirmed peripheral T\u2010cell lymphoma. The median age was 60 years and the male to female ratio was 1:1. A prior lymphoprolifera\u2010tive or autoimmune disorder was present in 14 per cent of the patients. Signs of advanced disease were usually present from the onset, such as B symptoms (55 per cent), generalized lymphadenopathy (57 per cent), stage III\/IV disease (62 per cent), and elevated levels of serum lactate dehydrogenase (68 per cent). Primary extranodal disease (14 per cent), hepatomegaly (12 per cent), splenomegaly (12 per cent), lung\/pleural involvement (12 per cent), skin involvement (21 per cent), and bone marrow involvement (28 per cent) were uncommon. Lymphocytopenia was present in 64 per cent of the patients, and none of nine patients tested were serologically positive for human T\u2010cell leukemia\/lymphoma virus (HTLV\u2010I) infection. Among 38 patients receiving combination chemotherapy, 20 (53 per cent) achieved a complete remission. The actuarial median survival of all patients was 17 months. Age greater than 60 years and stage III\/IV disease predicted a poor clinical outcome, whereas the large cell histological subtype predicted a favourable outcome. Prospective clinical studies using uniform treatments and a uniform histologic classification scheme are needed to confirm these findings.<\/jats:p>","DOI":"10.1002\/hon.2900050304","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T20:53:29Z","timestamp":1171918409000},"page":"175-187","source":"Crossref","is-referenced-by-count":27,"title":["Peripheral T\u2010cell lymphoma: A clinicopathologic study of 42 cases"],"prefix":"10.1002","volume":"5","author":[{"given":"Dennis D.","family":"Weisenburger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Linder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James O.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,3,6]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(86)80128-9"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/79.3.285"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-4-543"},{"key":"e_1_2_1_5_1","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone P. P.","year":"1971","journal-title":"Cancer Res."},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19841001)54:7<1310::AID-CNCR2820540714>3.0.CO;2-9"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood.V58.1.45.45","article-title":"Factors predicting long\u2010term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma","volume":"58","author":"Fisher R. I.","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcp\/83.1.18","article-title":"Nonendemic adult T\u2010cell leukemia\/lymphoma in the United States: Report of two cases and review of the literature","volume":"83","author":"Foucar K.","year":"1985","journal-title":"Am. J. Clin. Pathol."},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/52.1-2.203"},{"key":"e_1_2_1_10_1","first-page":"1078","article-title":"Eosinophils and immune mechanisms. III. Production of lymphokine eosinophil stimulation promotor by mouse T lymphocytes","volume":"116","author":"Greene B. M.","year":"1976","journal-title":"J. Immunol."},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.7.788"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/83.3.279"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01008087"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood.V67.6.1578.1578","article-title":"Clinical and phenotypic diversity of T\u2010cell lymphomas","volume":"67","author":"Horning S. J.","year":"1986","journal-title":"Blood"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/07357908409040316"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198404000-00003"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(83)80299-8"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21979"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1983.tb02267.x"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood.V58.1.52.52","article-title":"Immunoblastic sarcoma of T\u2010cell versus B\u2010cell origin: I. Clinical features","volume":"58","author":"Levine A. M.","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_21_1","first-page":"322","article-title":"Immunologic approach to non\u2010Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases","volume":"15","author":"Lukes R. J.","year":"1978","journal-title":"Sem. Hematol."},{"key":"e_1_2_1_22_1","first-page":"657","article-title":"The immunologic approach to the pathology of malignant lymphomas","volume":"72","author":"Lukes R. J.","year":"1979","journal-title":"Am. J. Clin. Pathol."},{"key":"e_1_2_1_23_1","first-page":"105","article-title":"Malignant lymphomas: A conceptual understanding of morphologic diversity","volume":"94","author":"Mann R. B.","year":"1979","journal-title":"Am. J. Pathol."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900010209"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V68.4.837.837"},{"key":"e_1_2_1_26_1","first-page":"670","article-title":"Immunologic basis for redefinition of malignant lymphomas","volume":"72","author":"Parker J. W.","year":"1979","journal-title":"Am. J. Clin. Pathol."},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/72.4.540"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(85)80128-3"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60456-X"},{"key":"e_1_2_1_30_1","first-page":"443","article-title":"Peripheral T\u2010cell malignancy as a problem in lymphoma classification","volume":"9","author":"Suchi T.","year":"1979","journal-title":"Jpn. J. Clin. Oncol."},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2"},{"key":"e_1_2_1_32_1","first-page":"423","article-title":"T\u2010cell malignancies: Subclassification and interrelationship","volume":"9","author":"Watanabe S.","year":"1979","journal-title":"Jpn. J. Clin. Oncol."},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19801201)46:11<2472::AID-CNCR2820461128>3.0.CO;2-Z"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)61975-2"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19851015)56:8<2061::AID-CNCR2820560829>3.0.CO;2-2"},{"key":"e_1_2_1_36_1","first-page":"316","article-title":"Morphologic and immunologic characterization of 50 peripheral T\u2010cell lymphomas","volume":"118","author":"Weiss L. M.","year":"1985","journal-title":"Am. J. Pathol."},{"key":"e_1_2_1_37_1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1182\/blood.V59.5.913.913","article-title":"The immunologic phenotyping of bone marrow biopsies and aspirates: Frozen section techniques","volume":"59","author":"Wood G. S.","year":"1982","journal-title":"Blood"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2900050304","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2900050304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T14:43:04Z","timestamp":1697899384000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2900050304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,7]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1987,7]]}},"alternative-id":["10.1002\/hon.2900050304"],"URL":"https:\/\/doi.org\/10.1002\/hon.2900050304","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,7]]}}}